Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United Sts Brent Oil Fd Lp Unit
BNO
US Stock MarketDetailed Quotes
Myriad Genetics (MYGN)
- 4.790
- -0.290-5.71%
Close Apr 23 15:59 ET
- 4.790
- 0.0000.00%
Post 16:10 ET
452.38MMarket Cap-1.21P/E (TTM)
5.065High4.545Low1.20MVolume5.040Open5.080Prev Close5.70MTurnover1.51%Turnover RatioLossP/E (Static)94.44MShares8.59052wk High1.23P/B381.51MFloat Cap3.76052wk Low--Dividend TTM79.65MShs Float69.000Historical High--Div Yield TTM10.24%Range %1.438Historical Low4.740Avg Price1Lot Size
Myriad Genetics (MYGN) Key Financial Indicators
MYGN Earnings per Share (EPS)
According to the latest financial report of Myriad Genetics, the latest earnings per share (TTM) for the company is -0.08. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
MYGN Free Cash Flow (FCF)
Interested in knowing about Myriad Genetics's free cash flow? The latest report shows it as 4.60M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
MYGN Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Myriad Genetics shows that the company's current ratio is 2.49, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
MYGN Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Myriad Genetics, the quick ratio is 1.98, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
MYGN Return on Equity (ROE)
Want to learn more about the financial health of Myriad Genetics? The latest ROE figure is -2.13%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
MYGN Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Myriad Genetics, the total asset return on investment (ROA) is -1.10%.
Currency: USD
Quarterly
Loading...
MYGN Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Myriad Genetics's latest financial report to see how their gross margin is doing - currently at 69.97%.
Currency: USD
Quarterly
Loading...
MYGN Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Myriad Genetics, the net profit margin is -3.77%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm